Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2005
12/08/2005WO2004093805A3 Selective spirocyclic glucocorticoid receptor modulators
12/08/2005WO2004078682A3 Cyclic compounds and compositions as protein kinase inhibitors
12/08/2005US20050272768 Process for preparation of amorphous form of a drug
12/08/2005US20050272762 Thienopyridines as IKK inhibitors
12/08/2005US20050272754 Polymorphic forms of rifaximin, processes for their production and uses thereof
12/08/2005US20050272730 Thienopyridazines as IKK inhibitors
12/08/2005US20050272721 Stable salts of olanzapine
12/08/2005US20050272720 Process for making olanzapine Form I
12/08/2005US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent
12/08/2005US20050272132 For therapy of a fungal infection
12/08/2005US20050269556 Polymer matrix and a compound of a photochromic moiety and an oligomer of polyether, polyalkylene polyfluoroalkylene, polyfluoroalkylenyloxy, polydi(C1 to C10 hydrocarbyl)siloxane, polysilicene acid; the photochromic adduct does not become covalently tethered to the polymer matrix
12/08/2005CA2565065A1 Therapeutic compounds: pyridine as scaffold
12/07/2005EP1601678A2 Fused pyrrole compounds
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601354A2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005EP1296987B1 Compounds for treating impaired fundic relaxation
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005CN1705672A New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle
12/07/2005CN1705671A Chemical intermediate
12/07/2005CN1705670A 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
12/07/2005CN1230437C Synthetic process for intermediate for ecteinascidin and phthalascidin compounds
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription
12/04/2005CA2568914A1 Therapeutic agents, and methods of making and using the same
12/01/2005WO2005113562A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113509A1 Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
12/01/2005WO2005052542A3 Method and composition useful for determining fk 506
12/01/2005US20050267303 Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals
12/01/2005US20050267115 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence
12/01/2005US20050267105 Bicyclic heterocycles as HIV integrase inhibitors
12/01/2005US20050267099 Reacting a des-piperazine olanzapine with an N-formyl piperazine to form an N-formyl olanzapine
12/01/2005US20050267048 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
12/01/2005CA2566755A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds
11/2005
11/30/2005EP1600180A2 Antiproliferative drug and delivery device
11/30/2005EP1599486A1 Preparation of k-252a
11/30/2005EP1599461A1 Thiolactones
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
11/30/2005EP1392702B1 Compounds and methods for inhibiting mrp1
11/30/2005CN1703408A Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229111C Sustained release preparations
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/24/2005WO2005111039A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
11/24/2005WO2005111030A1 Quinolone antibacterial agents
11/24/2005WO2005111015A1 Substituted pyrrolidine derivative
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110416A2 4,5-disubstituted-2-aryl pyrimidines
11/24/2005WO2005110410A2 Kinase inhibitors as therapeutic agents
11/24/2005WO2005079192A3 Novel treatment
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261494 Process for synthesis of dinitrotetraoxadiazaisowurzitane (DTIW)
11/24/2005US20050261493 Methods for the isolation and purification of ansamitocins
11/24/2005US20050261322 HIV integrase inhibitors
11/24/2005US20050261284 Diazinopyrimidines
11/24/2005US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods
11/24/2005US20050261262 Rifamycin derivatives effective against drug-resistant microbes
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2566158A1 Kinase inhibitors as therapeutic agents
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2563607A1 4,5-disubstituted-2-aryl pyrimidines
11/24/2005CA2508065A1 Antiproliferative drug and delivery device
11/23/2005EP1598359A1 Process for synthesis of dinitrotetraoxadiazisowursitane (DTIW)
11/23/2005EP1597264A2 Antiparasitic terpene alkaloids
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005CN1701075A Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
11/23/2005CN1699367A Process for synthesis of dinitrotetraoxadiazaisowurzitane (dtiw)
11/22/2005US6967205 Compounds with antibacterial and antiparasitic properties
11/22/2005US6967198 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/22/2005US6967079 Pyrimidine derivatives for labeled binding partners
11/17/2005WO2005107760A1 Compounds and compositions as inducers of keratinocyte differentiation
11/17/2005WO2005095401A8 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005US20050256313 Co-surfactants based on aldehydes
11/17/2005US20050256310 Therapeutic compounds
11/17/2005US20050256309 Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
11/17/2005US20050256154 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
11/17/2005US20050256153 Thienopyridinone compounds and methods of treatment
11/17/2005US20050256152 Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/17/2005US20050256140 Condensed pyridines and pyrimidines with tie2 (tek) activity
11/17/2005US20050256124 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
11/17/2005US20050256119 selective serotonine (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenocptor antagonist activity; To treat anxiety, movement disorders, psychosis, Parkinson's disease and body weight disorders including anorexia nervosa and bulimia without being sedative
11/17/2005US20050256109 HIV integrase inhibitors: cyclic pyrimidinone compounds
11/17/2005US20050256108 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension
11/17/2005US20050256102 Inhibit Aurora kinase; cancer; 4-[9-Chloro-7-(2-fluoro-phenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino]-N-(2-methylamino-ethyl)-benzamide; 9-Chloro-N-(4-{[3-(dimethylamino)azetidin-1-yl]carbonyl}phenyl)-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-amine
11/17/2005US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/17/2005US20050256096 Having another functional group or pharmacophore covalently attached through a carbamate linkage, e.g., 25-O-Desacetyl-N-(1-carbonyl-4-methyl-piperazine) 3-morpholino rifamycin S; dual-function antibiotic mechanism provides for reduced frequency of resistance.
11/17/2005US20050255465 Novel fluorescent label compounds
11/16/2005EP1595884A2 Salt of sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
11/16/2005EP1594865A2 Antibacterial agents
11/16/2005EP1594495A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
11/16/2005EP1421634B1 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/10/2005WO2005106007A1 Labeling of rapamycin using rapamycin-specific methylases
11/10/2005WO2005105814A1 Tetracyclic inhibitors of janus kinases
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 220